Skip to main content
Anthony Faugno IV, MD, Pulmonology, Boston, MA

AnthonyJFaugnoIVMD

Pulmonology Boston, MA

Critical Care Medicine, Pulmonary Vascular Medicine

Pulmonary Critical Care Fellow PGY6

Dr. Faugno is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Faugno's full profile

Already have an account?

  • Office

    800 Washington Street
    Boston, MA 02111
    Phone+1 617-636-5000

Summary

  • Dr. Anthony Faugno is a pulmonologist in Boston, MA and is affiliated with Tufts Medical Center. He received his medical degree from Drexel University College of Medicine and has been in practice 5 years. He specializes in critical care medicine and pulmonary vascular medicine.

Education & Training

  • Tufts Medical Center
    Tufts Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2015 - 2018
  • Tufts Medical Center
    Tufts Medical CenterResidency, Internal Medicine, 2012 - 2015
  • Drexel University College of Medicine
    Drexel University College of MedicineClass of 2012

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2015 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Critical Care Medicine
  • American Board of Internal Medicine Pulmonary Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association Between Early Treatment with Tocilizumab and Mortality Among Critically Ill Patients with COVID-19  
    Kusum S Mathews, Michal L Melamed, Samantha K Brenner, Amanda Leonberg-Yoo, Edward J Schenck, Jared Radbel, Jochen Reiser, Anip Bansal, Diana Finkel, Mary Mallappallil..., JAMA Internal Medicine

Press Mentions

  • Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
    Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineDecember 30th, 2020

Professional Memberships